首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >A pH-sensitive carrier based-on modified hollow mesoporous carbon nanospheres with calcium-latched gate for drug delivery
【24h】

A pH-sensitive carrier based-on modified hollow mesoporous carbon nanospheres with calcium-latched gate for drug delivery

机译:基于pH敏感的载体基于修饰的中空介孔碳纳米载体,用于药物递送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A novel nanocarrier based-on hollow mesoporous carbon nanospheres (HMCNs) with primary amines on its surface, a large cavity, and good hydrophilicity was synthesized by a hydrothermal reaction. The primary amine functionalities on the mesoporous carbon were used as the initiation sites for growing poly (epichlorohydrin) (PCH) chains. The chlorine groups in the side chain of PCH were replaced with imidazole as the pendant groups. Calcium chloride (CaCl2) was applied as a capping agent. The coordination bonding was formed between pendant imidazole groups and calcium ions. Doxorubicin (DOX) was selected as a model of hydrophilic anticancer drug and was loaded onto the nanocarrier and released through the cleavage of the pH-sensitive coordination bonding. The gating mechanism enables the nanocarrier to store and release the calcium ions and the DOX molecules trapped in the pores. MTT assay toward HeLa cells indicated that the nanocarrier had low toxicity because of the surface modification with the oxygen-rich polymer. The cellular uptake of the pH-sensitive nanocarrier for HeLa cancer cell lines was confirmed by CLSM images and flow cytometry. So, the novel pH-sensitive nanocarrier can be applicable to carry and release both DOX drug and calcium ions for cancer treatment.
机译:通过水热反应合成了基于其表面,大胺的新型纳米载波的中空介孔碳纳米球(HMCNS),具有大胺,具有良好的亲水性和良好的亲水性。中孔碳上的伯胺官能团用作生长聚(表氯醇)(PCH)链的引发位点。将PCH侧链中的氯基团用咪唑作为侧链代替。将氯化钙(CaCl 2)作为封端剂施加。在悬浮咪唑基团和钙离子之间形成配位键合。选择多柔比星(DOX)作为亲水性抗癌药的模型,并加载到纳米载体上并通过pH敏感配位键合的切割释放。门控机构使纳米载体能够储存和释放钙离子和被困在孔中的DOX分子。 MTT测定朝向HeLa细胞表明,由于具有富氧聚合物的表面改性,纳米载体具有低毒性。通过CLSM图像和流式细胞术确认了Hela癌细胞系的pH敏感纳米载体的细胞吸收。因此,新型pH敏感的纳米载体可以适用于携带和释放DOX药物和钙离子以进行癌症治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号